Mercanti, I.
18  Ergebnisse:
Personensuche X
?
3

Stochastic modeling and analysis of the bitcoin protocol in..:

Bistarelli S ; De Nicola R ; Galletta L...
info:eu-repo/semantics/altIdentifier/wos/WOS:000728134600001.  , 2021
 
?
4

T Regulatories (Tregs) and Suppressor Cytokine mRNA (IL-10,..:

De Mercanti, S. ; Cucci, A. ; Viglietta, E....
Neurology.  78 (2012)  Meeting Abstracts 1 - p. P02.088-P02.088 , 2012
 
?
6

A 1-bit digital dynamically biased power amplifier for step..:

, In: 2009 European Microwave Conference (EuMC),
Cidronali, A. ; Magrini, I. ; Fagotti, R... - p. None , 2009
 
?
7

Gut microbiota and metagenomic diversity in Clinical Isolat..:

Rolla, S ; Ferrocino, I ; Bardina, V...
info:eu-repo/semantics/altIdentifier/wos/WOS:000453090801327.  , 2018
 
?
8

Alterations in gut microbiome are associated with the onset..:

Rolla, S ; Bardina, V ; Ferrocino, I...
info:eu-repo/semantics/altIdentifier/wos/WOS:000446861401121.  , 2018
 
?
9

Extended interval dosing of natalizumab: is efficacy preser..:

Clerico, M ; Signori, A ; De Mercanti, S...
info:eu-repo/semantics/altIdentifier/wos/WOS:000446861400441.  , 2018
 
?
10

Six year prospective immunological study of alemtuzumab tre..:

Durelli, L ; Rolla, S ; De Mercanti, S...
info:eu-repo/semantics/altIdentifier/wos/WOS:000413730205192.  , 2017
 
?
11

Gut microbiota alteration in Clinically Isolated Syndrome: ..:

Rolla, S ; Bardina, V ; Ferrocino, I...
info:eu-repo/semantics/altIdentifier/wos/WOS:000413730204346.  , 2017
 
?
12

Alemtuzumab long-lasting immunological effects: a 48 months..:

Durelli, L ; De Mercanti, SF ; Cucci, A...
info:eu-repo/semantics/altIdentifier/wos/WOS:000383267201365.  , 2016
 
?
13

Treatment of Relapsing-Remitting Multiple Sclerosis After 2..:

Clerico, M ; Schiavetti, I ; De Mercanti, SF...
info:eu-repo/semantics/altIdentifier/wos/WOS:000340481800004.  , 2014
 
?
14

Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Mul..:

Rolla S ; De Mercanti S. F ; Bardina V...
info:eu-repo/semantics/altIdentifier/pmid/35296069.  , 2022
 
?
15

SARS-CoV-2 serology after COVID-19 in multiple sclerosis: A..:

Sormani M. P ; Schiavetti I ; Landi D...
info:eu-repo/semantics/altIdentifier/pmid/34328824.  , 2022
 
1-15